标普和纳斯达克内在价值 联系我们

Salarius Pharmaceuticals, Inc. SLRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Salarius Pharmaceuticals, Inc. (SLRX) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 46/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
49/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
100/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
28/100
→ Income
成长
15/100
→ Income
收入
N/A
No coverage

估值概览 — SLRX

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-25.99
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-12,150.00 $1.01M $-39.49M -3907.6%
2017 $-9,950.00 $1.27M $-34.43M -2701.7%
2018 $-6,100.00 $838.14K $-21.92M -2615.6%
2019 $-424.00 $3.47M $-6.94M -200.2%
2020 $-100.00 $5.23M $-7.35M -140.5%
2021 $-62.00 $1.84M $-12.77M -693.8%
2022 $-14.77 $0.00 $-31.37M -
2023 $0.00 $0.00 $-12.54M -
2024 $-5.79 $0.00 $-5.58M -
2025 $-25.99 $0.00 $-12.52M -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言